Clinical and Epidemiological Aspects of Acute Q Fever in Reunion Island over Fourteen Years: A Retrospective Cohort Study.
Alexandra AubinCarole EldinNaël ZemaliJulien JaubertYatrika KoumarMarie-Pierre MoitonPatrice PoubeauEric BraunbergerPatrick GerardinAntoine BertolottiPublished in: Microorganisms (2023)
The clinical characteristics and epidemiology of Q fever in the Tropics are poorly described. We performed a retrospective cohort study of hospitalized cases between 2004 and 2017 in Reunion Island. Acute Q fever was defined in presence of a positive serology (phase II IgG ≥ 200 and phase II IgM ≥ 50), or a seroconversion (4-fold increase in phase II IgG between paired samples), or a positive PCR (blood or serum). Forty-two cases matched the diagnostic criteria. The most common clinical manifestations were fever (85.7%) and pulmonary symptoms (61.9%), including pneumonia (45.2%). Ninety percent of the patients were living in a farming area. Cumulative incidence was estimated at 9.3 per 100,000 inhabitants (95%CI: 6.4-12.1) with cases diagnosed yearly all throughout the study period except in 2006. Together with the seroprevalence figures, these data suggest that Q fever reaches low to moderate endemic levels on Reunion Island. As previously reported, pulmonary symptoms are in the foreground.
Keyphrases
- phase ii
- clinical trial
- open label
- phase iii
- liver failure
- placebo controlled
- respiratory failure
- end stage renal disease
- double blind
- pulmonary hypertension
- risk factors
- ejection fraction
- chronic kidney disease
- newly diagnosed
- drug induced
- prognostic factors
- study protocol
- machine learning
- physical activity
- real time pcr